Solvay Shares Fall 2.44%, Among the Biggest Declines in the SBF 120
The Belgian chemical company significantly declines at mid-session in a downward trending Paris market. The Belgian chemical company significantly declines at mid-session and is among the biggest losers in the SBF 120, erasing part of its early-week rebound linked to the rare earth agreement.
Solvay Moves Below Its Three Moving Averages, Approaching Support at €25.30
Solvay shares drop 2.44% to €25.58, among the steepest declines in the SBF 120 which is down by 0.51%. The stock ranks low today, following the trail of Imerys, Arkema, and Forvia, all penalized in the session.
The price has fallen below its three moving averages: MM20 (€26.20, gap -2.37%), MM50 (€26.87), and MM200 (€26.96, gap -5.12%). This configuration indicates a loss of momentum in both the short and medium term.
The decline brings the stock closer to the identified support threshold at €25.30, about 1.1% from the current price. The RSI at 48 remains neutral, indicating that today's drop has not yet moved into oversold territory.
Today's Movement Corrects the Rebound Begun in Late May
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
In today's session, the macro environment weighs on European cyclical stocks. The CAC 40 is down 0.54% and the DAX loses 0.76%, in a context of a dollar at a two-month high following a strong US employment report and increased likelihood of a Fed rate hike.
Over the year, the stock has declined by 10.81%. The support threshold at €25.30 will be the next technical marker to watch.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
